The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy

Clinical approaches to overcome PARP inhibitor resistance

Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability

NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation